A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CSME / clinically significant macular edema

[Related PubMed/MEDLINE]
Total Number of Papers: 171
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CSME  (>> Co-occurring Abbreviation)
Long Form:   clinically significant macular edema
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Design, Development, and Evaluation of a Teleophthalmology System Using a Low-Cost Fundus Camera. GPs
2019 IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. DME, DR, NPDR, PDR
2019 MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus. DME, DR, GWAS, NPDR, OR, PDR, SNPs
2019 Novel Triamcinolone Acetonide-Loaded Liposomal Topical Formulation Improves Contrast Sensitivity Outcome After Femtosecond Laser-Assisted Cataract Surgery. CFT, CS, FLACS, TA-LF, TMV
2019 Retinal images benchmark for the detection of diabetic retinopathy and clinically significant macular edema (CSME). DR, NPDR, NVD, NVE, PDR
2019 Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study. AER, DBP, DCCT, EDIC, PDR, T1D
2019 Screening eye exams in youth with type 1 diabetes under 18 years of age: Once may be enough? DCCT, ETDRS, T1D
2019 Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab. PDR, PRP
2018 Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study. CI, DME, DR, HbA1c, LDL, OR, SEED, VTDR
10  2018 European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. CME
11  2018 Optimal screening schedules for disease progression with application to diabetic retinopathy. PDR
12  2018 The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy. CI, DR, OR, PDR, RVGCs, T1DM, T2DM
13  2017 A Revised Approach for the Detection of Sight-Threatening Diabetic Macular Edema. ---
14  2017 Color vision abnormalities in type II diabetes: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study II report no 2. ETDRS, ICV, IOP, OR
15  2017 Frequency of diabetic retinopathy and associated risk factors in Khartoum, Sudan: population based study. DM, NPDR, PDR
16  2017 The Prevalence of Diabetic Retinopathy in Australian Adults with Self-Reported Diabetes: The National Eye Health Survey. CI, DR, OR, PDR, VTDR
17  2016 A Hospital Based Study Regarding Awareness of Association Between Glycosylated Haemoglobin and Severity of Diabetic Retinopathy in Type 2 Diabetic Individuals. DR
18  2016 A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography. DM, DR, FAZ, HR, OCT, VR
19  2016 American Society of Anesthesiologists classification in cataract surgery: Resultsfrom the Ophthalmic Surgery OutcomesData Project. ASA, CDVA, CI, NEI-VFQ, OR, VRQL
20  2016 Comparison of Prevalence of Diabetic Macular Edema Based on Monocular Fundus Photography vs Optical Coherence Tomography. CST, DME, MESA, NHANES, OCT
21  2016 National Eye Institute Visual Function Scale in Type 2 Diabetes Patients. CSCat, DA, DRP, ICDRS, NVA
22  2016 The combination of phacoemulsification surgery and intravitreal triamcinolone injection in patients with cataract and diabetic macular edema. BCVA, CMT, IOP, IVTA, PHACO
23  2016 The use of optical coherence tomography (OCT) to evaluate the efficacy of different photo-coagulations in diabetic macular edema treatment. NPDR, OCT, PRP
24  2016 Visual outcome of laser treatment in diabetic macular edema: Study from an Urban Diabetes Care Center. BCVA, DAP
25  2015 Changes in vision related quality of life in patients with diabetic macular edema: ranibizumab or laser treatment? CRT, DME, IVR, VRQoL
26  2015 Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy. DR, NPDR, PDR
27  2015 Diabetic retinopathy with or without clinically significant macular edema: The influencing factors. ETDRS, HDL, LDL, TG
28  2015 Effect of grid decentration on macular thickness measurements in normal subjects and patients with diabetic macular edema. CST, CSV, OCT
29  2015 Improving Accuracy of Grading and Referral of Diabetic Macular Edema Using Location and Extent of Hard Exudates in Retinal Photography. DME, HE, OCT
30  2015 Macular thickness measurement in clinically significant macular edema before and after meal. CST, MRT
31  2015 Posterior sub-tenon's bevacizumab injection in diabetic macular edema; a pilot study. ---
32  2015 Relationship of systemic endothelial function and peripheral arterial stiffness with diabetic retinopathy. AI, DR, EndoPAT, RHI
33  2015 Repeatability of Retinal Macular Thickness Measurements in Healthy Subjects and Diabetic Patients with Clinically Significant Macular Edema: Evaluation of the Follow-Up System of Spectralis Optical Coherence Tomography. CR, CSF, OCT
34  2015 Repeatability of Retinal Macular Thickness Measurements in Patients with Clinically Significant Macular Edema Using Two Different Scanning Protocols of Spectralis Optical Coherence Tomography. CSF, OCT
35  2015 Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis. DME, DR, NPDR, PDR
36  2015 The association between chronic kidney disease and diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2010. aOR, CI, CKD, DR, OR, VTDR
37  2014 A multiscale optimization approach to detect exudates in the macula. AUC, IA, PLS
38  2014 Effect of adding oral calcium dobesilate to laser photocoagulation on the macular thickness in patients with diabetic macular edema: a randomized clinical trial. ---
39  2014 Fundus autofluorescence characteristics in patients with diabetic macular edema. BCVA, CRT, CRV, dFAF, DME, ELM, FAF, iFAF, IS/OS, MS, SD-OCT
40  2014 Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy. MA
41  2014 Prevalence of systemic co-morbidities in patients with various grades of diabetic retinopathy. eGFR, PVD
42  2014 Role of brimonidine in the treatment of clinically significant macular edema with ischemic changes in diabetic maculopathy. BMD, FAZ
43  2014 The correlation between retinal sensitivity assessed by microperimetry and contrast sensitivity in diabetic macular oedema. CS, DR, MP, RS, RT
44  2014 Utility of hard exudates for the screening of macular edema. HEs
45  2013 Early phacoemulsification in diabetic cataract for early recognition and management of diabetic macular oedema. BCVA, NPDR, PDR
46  2013 Higher age at onset of type 1 diabetes increases risk of macular oedema. ---
47  2013 Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy. MA, NPDR
48  2013 Prevalence of Diabetic Retinopathy in Western Indian Type 2 Diabetic Population: A Hospital - based Cross - Sectional Study. DR
49  2013 Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial. DCCT, DR, hs-CRP, ICAM-1, RR
50  2013 Quantitative computerized color vision testing in diabetic retinopathy: A possible screening tool? AUC, DME, DR, OCT, ROC
51  2013 Repeatability and reproducibility of retinal thickness measurements in diabetic patients with spectral domain optical coherence tomography. ICCs, OCT
52  2013 Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes. DME, NPDR, OCT
53  2013 Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema. MA, NPDR, OCT, RT
54  2013 [Relationship between macular morphology and visual function in diabetic macular edema]. NCSME, OCT
55  2012 A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. BCVA, BOLT, ETDRS, MLT
56  2012 Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. DR, ETDRS, SLO
57  2012 Atorvastatin in clinically-significant macular edema in diabetics with a normal lipid profile. ---
58  2012 Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: a case report. ME
59  2012 Expected value of foveal thickness in macular edema in Mexican patients with diabetes. CSMT
60  2012 High prevalence of sleep disordered breathing in patients with diabetic macular edema. SDB
61  2012 Is laser photocoagulation still effective in diabetic macular edema? Assessment with optical coherence tomography in Nepal. ANOVA, BCVA, CMO, OCT, TMV, VEGFs, VMIA
62  2012 Neodymium: yttrium-aluminum-garnet laser anterior hyaloidotomy to treat trapped triamcinolone acetonide behind the crystalline lens after intravitreal injection. IVTA
63  2012 Optical coherence tomographic assessment of macular thickness and morphological patterns in diabetic macular edema: prognosis after modified grid photocoagulation. ANOVA, BCVA, CME, CMT, OCT, SFD, ST, VMIA
64  2012 Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes. BMI, BP, FBG, HDL, LDL, NPDR, TG
65  2012 Serum lipids and diabetic retinopathy: A cross-sectional study. BCVA, DR
66  2012 The effect of glycemic control on visual and anatomic outcomes in response to therapy for diabetic macular edema. BCVA, CFT
67  2012 [Characteristics associated with visual improvement after focal photocoagulation in diabetic macular edema]. OCT
68  2012 [Navigated focal retinal laser therapy using the NAVILAS system for diabetic macula edema]. CI, DME, ITT, OCT
69  2011 Alpha-lipoic acid for the prevention of diabetic macular edema. ALA, IDDM
70  2011 Automatic detection of diabetic retinopathy and age-related macular degeneration in digital fundus images. AMD, AUC, DD, DR, FOV, ROC, STDR, UTHSCSA
71  2011 Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus. CI, DME, DR, DRCR.net
72  2011 Diabetic macular edema: fundus autofluorescence and functional correlations. BCVA, CRT, DME, FAF, OCT
73  2011 Differential association of serum lipids with diabetic retinopathy and diabetic macular edema. DME, DR, OCT
74  2011 Foveal cystoid spaces are associated with enlarged foveal avascular zone and microaneurysms in diabetic macular edema. CME, DME, FA, FAZ, MAs, PCN, SD-OCT, SRD
75  2011 Intraocular pressure and its determinants in subjects with type 2 diabetes mellitus in India. CCT, DM, IOP
76  2011 Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography. RT
77  2011 Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy. DR
78  2011 Practice patterns of Canadian vitreoretinal specialists in diabetic macular edema treatment. DME, FAZ, IVT, VR
79  2011 Prophylaxis of macular edema with intravitreal ranibizumab in patients with diabetic retinopathy after cataract surgery: a pilot study. DR, NPDR
80  2011 Risk factors for progression of subclinical diabetic macular oedema. CSMT, SCME, VA
81  2011 Subthreshold micropulse diode laser and double frequency neodymium: YAG laser in treatment of diabetic macular edema: a prospective, randomized study using multifocal electroretinography. BCVA, DME, mfERG, OCT, SDM
82  2011 [Effect of photocoagulation on center point thickness in diabetic macular edema]. CPT
83  2010 Association of systemic risk factors with the severity of retinal hard exudates in a north Indian population with type 2 diabetes. HDL, LDL, NPDR, TG, VLDL
84  2010 Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME. BCVA, OCT, RT
85  2010 Comparison of multiple stereoscopic and monoscopic digital image formats to film for diabetic macular edema evaluation. DME, HE, RT, RTCM
86  2010 Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. DR, ME, NPDR, PDR
87  2010 Functional outcome of subthreshold versus threshold diode laser photocoagulation in diabetic macular oedema. BCVA, CMT, CS, OCT, PSRT
88  2010 Impact of diabetic retinopathy on vision-specific function. DR, ME, PDR, VTDR
89  2010 Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. CI, ETDRS, HDL, LDL, NCEP ATP III, non-CSME, OR
90  2010 Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy. BCVA, CMT, IVTA, PRP
91  2010 Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. BCVA, CMT, IVTA, logMAR, MPC, OCT, PDR, PRP, SCMT
92  2010 Pattern electroretinogram changes after intravitreal bevacizumab injection for diabetic macular edema. PERG
93  2010 Ranibizumab for diabetic macular edema difficult to treat with focal/grid laser. BCVA, CRT
94  2009 Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. CSF, IGF-1, OCT, VEGF
95  2009 Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. PDR, T1DM, VA
96  2009 Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. BCVA, CMT, IVTA, logMAR, PDR, TMV
97  2009 Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. CI, DM, DR, NPDR, OR, PDR, SNPs, T1DM, T2DM, VEGF
98  2009 Comparison of diabetic retinopathy phenotype between Latinos and Blacks. ACR, DR, FA, FP
99  2009 Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines. ADMA, NPDR, PDR, SDMA
100  2009 Diabetic retinopathy is not associated with carbonic anhydrase gene polymorphisms. CA, DR, NPDR, PDR, PDR, T1DM, T2DM